Sleep & Anxiety Supplements: What Works, What Doesn't
Most natural sleep aids are safe and do a little, and none of them does what the marketing says. Magnesium, L-theanine and glycine may give small nudges. Melatonin is useful for resetting your body clock but adds only minutes of sleep for ordinary insomnia, and taking it nightly for years now carries an unconfirmed heart-failure signal. Several popular ones (GABA, valerian, phosphatidylserine, taurine, CBD) are oversold.
If you want to try one, start with 250 mg of magnesium (as bisglycinate) an hour or two before bed, optionally with 200 mg of L-theanine. Keep melatonin for jet lag or shifting your sleep time (0.3–1 mg for the latter), for a limited period. Combining magnesium and L-theanine hasn't been studied, though no interaction is known. If insomnia has lasted months, cognitive behavioural therapy for insomnia (CBT-I) is the treatment that works. Supplements are side help, not a fix.
Magnesium: the best place to start, and still a small effect
Magnesium works on the brain's main "go" and "stop" signals, damping the excitatory glutamate receptor and supporting GABA, the main calming signal.[1] The bisglycinate form, magnesium bound to glycine, is gentler on the gut than citrate or oxide.
The best trial is modest. In 155 adults who reported poor sleep, 250 mg a day of magnesium from bisglycinate improved a 0–28 insomnia questionnaire score by about 1.6 points more than placebo over four weeks.[2] That only just reached statistical significance; a clinically meaningful improvement came to 26 people on magnesium and 15 on placebo, roughly one extra person in seven. An exploratory analysis hinted that people who ate little magnesium responded best.
The wider evidence is thin. The meta-analysis usually cited for magnesium and sleep pooled just three trials and rated the evidence low-certainty.[3] A larger review of nine studies and 7,582 people found the usual split: in observational studies, people who eat more magnesium sleep better, but the trials contradict each other.[4] A crossover trial, an unpublished preprint by authors with supplement-industry ties, carries little weight.[5]
L-threonate is the "brain" form, and the brain part is rat data. The claim that it crosses into the brain comes from a rat study;[6] no human study has measured it. Every human trial of it for memory or sleep, including the two below, was funded or supplied by the ingredient's makers. In 100 adults over six weeks, 2 g a day beat placebo on only one of seven cognitive subtests (working memory), with no benefit on a reasoning test or on any sleep measure from participants' sleep-tracking rings. The ingredient's owner also helped design it, and it shares an author with the bisglycinate trial, so the two results are not independent.[7] A 21-day trial in 80 adults reported better ring-measured deep sleep and REM, but no gain on the validated insomnia questionnaire it used;[8] the manufacturer's funding was disclosed only in a later correction.[9] Tested against a lab sleep study, consumer trackers caught only about half to two-thirds of true deep-sleep periods,[10] newer wrist devices misjudged deep sleep by up to about 45 minutes depending on the brand,[11] and rings do no better: the best ring tested caught about half of true deep-sleep periods.[12] A change in a wearable's deep-sleep number is not evidence of a change in deep sleep. See Sleep architecture.
Watch the total dose. The European upper limit for magnesium from supplements is 250 mg a day, and the US limit is 350 mg. The common 200–400 mg range runs past the European figure, with no evidence the top of it works better. L-threonate is only about 7% magnesium, so the 2 g trial dose delivers 145 mg on its own.[13] Stacked with 250 mg of bisglycinate that is nearly 400 mg a day, already over both limits; with 400 mg it passes 500 mg. If you stack, lower one of the two.
Safety. Magnesium is very well tolerated, with no rebound insomnia. Avoid high doses if you have kidney disease. Take it at least two hours apart from quinolone or tetracycline antibiotics and from bisphosphonates, because it binds them.
L-theanine and glycine: small, cheap, low-risk, worth a modest try
L-theanine is the amino acid in tea that produces relaxed alertness without sedation. Across 897 people, a meta-analysis found small effects, all on how people rated their own sleep: falling asleep, sleep quality and daytime functioning.[14] It is not a treatment for an anxiety disorder: a meta-analysis of 31 trials found no benefit for clinical anxiety, while confirming a short-term gain in attention.[15]
A cup of tea has only about 5–30 mg, so the studied doses mean a supplement: 200 mg in the evening, or 200–400 mg a day for daytime calm. It is well tolerated, but in theory it may add to the effect of blood-pressure drugs, so take care if you are on several. Its combination with magnesium hasn't been studied.
Glycine, 3 g before bed, improved how people rated their sleep and next-day alertness in small trials.[16] But essentially all of this work comes from one research group at one amino-acid manufacturer, with no independent replication. It is very well tolerated. The flagship magnesium trial also delivered about 1.5 g of glycine a day, so the two effects can't be separated, and someone also taking 3 g of glycine gets roughly 4.5 g of glycine.
Melatonin: a clock-setter, not a sleeping pill
Melatonin is best used for delayed sleep timing, where the sleep-medicine guideline endorses it,[17] and for jet lag, which that guideline does not cover; its use for shift-work transitions has thinner support. The guideline recommends against it for older people with dementia, and the jet-lag evidence flags possible harm with epilepsy or warfarin — the melatonin page covers both.
For ordinary insomnia the gain is minutes. Across 19 trials and 1,683 people, melatonin got people to sleep about seven minutes faster and added about eight minutes of sleep.[18] The American Academy of Sleep Medicine's guideline on sleep drugs recommends, conditionally, against melatonin for insomnia in adults.[19] In Europe, a prolonged-release prescription form (2 mg) is licensed for insomnia in adults aged 55 and over, for up to three months.[20] That licence is why the insomnia case is strongest in older adults, but not because they lack melatonin: healthy older adults measured under controlled conditions make as much overnight as young adults.[21]
Dose depends on the goal. For delayed sleep timing, 0.3–1 mg timed correctly is what the evidence supports. For falling asleep, pooling 26 trials put the best dose near 4 mg, taken about three hours before bed rather than the usual half hour.[22] Nothing supports 10 mg, and bigger doses are more likely to leave you groggy.
The heart-failure signal. A 2025 conference presentation compared about 65,000 people who had taken melatonin for a year or more with matched non-users. Over five years, heart failure showed up in about 4.6% of users against 2.7%, and death in about 7.8% against 4.3%.[23] It is an abstract, not a peer-reviewed paper; it is observational, and long-term users tend to have worse insomnia, more depression and unrecorded use of other sleep drugs;[24] and it counted anyone buying melatonin over the counter as a non-user. So it does not prove harm, but it is large enough to argue against taking melatonin every night indefinitely.
Labels are unreliable. Among 31 supplements tested, actual melatonin ranged from 83% below to 478% above the label, and eight contained serotonin;[25] gummies were no better on dose, at 74% to 347% of the label, though none contained serotonin.[26]
One metabolic caveat. In one trial, 5 mg worsened glucose tolerance only in carriers of a common variant of the melatonin-receptor gene MTNR1B,[27] though across 31 trials melatonin slightly improved markers of insulin resistance.[28]
Ashwagandha: modest help for stress, and a real liver risk
Ashwagandha modestly reduced stress and anxiety in small, short trials, but a meta-analysis of 12 of them rated the certainty of that evidence low.[29] Several small trials show better sleep, mainly in stressed people or people with insomnia, and the US National Institutes of Health calls the sleep evidence suggestive.[30]
Choose a standardised root extract, such as KSM-66 at 300–600 mg a day, the dose used in its trials.[31] Leaf extracts have shown liver toxicity in laboratory cell studies.[32]
But a good brand is no guarantee for your liver. A review of 25 published liver-injury cases found no consistent dose pattern and no basis for blaming poor-quality or leaf-containing products — largely because formulation and plant part usually went unrecorded — and advised people with advanced liver disease to avoid it;[33] in the largest case series, the products were chemically clean, single-ingredient extracts.[34] Injury is uncommon and usually resolves on stopping. Denmark banned ashwagandha in food supplements in 2023.[35]
Avoid it in liver disease,[36] thyroid disease (it can stimulate the thyroid) and pregnancy, and don't combine it with sedatives — benzodiazepines, zolpidem-type drugs, opioids or alcohol — because the sedation adds up.[37] It is also commonly advised against in autoimmune conditions. It mildly lowers blood pressure and blood sugar, so monitor if you take drugs for either, and it affects a liver enzyme that processes many prescription drugs.[38] No dependence has been documented, but long-term data is limited.
The ones to skip, or try with low expectations
Apigenin (about 50 mg), the flavonoid in chamomile, enhances calming signalling in rats, which has not been shown in people.[39] Direct human trials at 50 mg are thin; most support comes from whole-chamomile studies and animal work, and safety at typical doses is good.[40] The longevity pitch, that it preserves the cellular energy molecule NAD⁺, is animal data only.[41] Fine to try for mild trouble falling asleep; expect gentle.
Oral GABA barely crosses into the brain.[42] People in some studies feel they fall asleep a little faster, but measured sleep generally doesn't beat placebo.[43] Skip it.
Valerian has a good safety record. A review of eight systematic reviews found it appears to improve how people rate their sleep but has never moved measured sleep.[44] The older literature was mixed the same way.[45] The common advice to cycle it on and off is folklore: no trial has tested tolerance, and long-term safety is unknown.[46] Side effects are mild, such as morning grogginess and vivid dreams, though very rare liver injury has been reported, mostly with other herbs.[47] Don't use it in pregnancy, in children, or with other sedatives.
Phosphatidylserine has no controlled trials that we could find for sleep or anxiety in adults. The one recent trial, in children, missed its main goals.[48] It may also weaken anticholinergic medicines.
Taurine became a longevity story by extending healthy lifespan in middle-aged mice by up to 12%.[49] Human data then showed blood taurine does not reliably fall with age.[50] It is not a sleep aid.
CBD has mixed sleep results and poorly controlled products. It blocks liver enzymes that clear statins, warfarin and many other drugs.[51] In a US Food and Drug Administration trial, about 350 mg a day for 28 days, the top of what people take rather than a typical gummy, pushed liver enzymes above three times normal in roughly one healthy adult in twenty.[52] Skip it unless you have a specific medical reason.
Can you get hooked?
On the evidence available, no. None of these supplements produces addiction, tolerance or withdrawal at the doses studied, and that is their main advantage over sleeping pills.
The drugs they are compared against do. The full comparison lives in Treating chronic insomnia; in brief, benzodiazepines and zolpidem-type drugs carry tolerance, dependence and withdrawal, while over-the-counter antihistamine sleep aids such as diphenhydramine lose their sedating effect within days,[53] and their misuse is documented, mostly in case reports.[54] The first two are linked to hip fractures,[55] and heavy long-term use of anticholinergic drugs, the antihistamines' class, tracks with higher dementia risk in people over 65.[56] One model estimated that if Americans over 50 stopped prescription sleep medication, lifetime falls would drop by 8.5%.[57]
The newer orexin-blocking drugs (suvorexant, lemborexant, daridorexant) show no tolerance or rebound when stopped, but they are controlled substances: recreational sedative users rate them as more likeable than placebo, though daridorexant at its prescribed dose rated less likeable than an above-normal dose of zolpidem.[58] Real-world abuse reports are very low.[59]
Three caveats: "no chemical addiction" doesn't rule out feeling you can't sleep without it; absence of withdrawal has never been tested, because the trials run three to six weeks and don't study stopping; and data on more than a year or two of daily use is limited for most of these.
Why CBT-I beats every bottle
Even the best supplement here has a small effect. CBT-I has large effects that persist after treatment ends, and guidelines put it ahead of any drug.[60] No head-to-head trial has put a number on the gap; the clear difference is durability. CBT-I works on what keeps chronic insomnia going, the learned arousal and anxiety about sleep, which no supplement touches.
It is badly underused: in Sweden in 2024, roughly 870,000 people collected a sleeping-pill prescription, against about 600 recorded as getting internet-delivered CBT-I. That figure comes from a university news item and undercounts therapy delivered in person, but the gap is huge.[61]
Why this matters for ageing. Chronic insomnia is linked to faster-ticking "epigenetic clocks", the DNA-based estimates of biological age, in small cross-sectional studies.[62] Genetic analysis points the same way.[63] More regular daily rest-activity rhythms track with slower epigenetic ageing on two of four clocks, again in a one-time snapshot.[64] No sleep supplement has been shown to slow these clocks.
Tier ranking summary
| Supplement | Evidence | Safety | Addiction risk | Verdict |
|---|---|---|---|---|
| Magnesium bisglycinate | Weak (low-certainty) | Excellent | None | Worth trying |
| L-theanine | Weak (sleep, self-rated only); none shown (anxiety) | Excellent | None | Worth trying for sleep |
| Magnesium L-threonate | Manufacturer-linked trials only | Good | None | Optional; count the magnesium |
| Melatonin (low dose) | Moderate for body-clock problems; weak for insomnia | Good short-term; heart caution long-term | None | For specific uses, not nightly forever |
| Ashwagandha | Modest, low-certainty (stress, anxiety); suggestive (sleep) | Moderate (liver injury, interactions) | None documented | Selective use, root extract only |
| Glycine | Weak | Excellent | None | Optional |
| Apigenin | Weak, preliminary | Good | None | Optional |
| Phosphatidylserine | No adult sleep or anxiety trials | Good | None | Skip |
| Valerian | No measured benefit | Good short-term; long-term unknown | None documented (untested) | Skip |
| Taurine | Not a sleep aid | Good | None | Not for sleep |
| GABA (oral) | Weak, mostly negative | Good | None | Skip |
| CBD | Weak, preliminary | Variable (drug interactions, liver enzymes) | None documented | Skip without a medical reason |
Further reading
- Schuster J et al. Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial. Nat Sci Sleep 2025.[65]
- Arab A et al. The Role of Magnesium in Sleep Health: a Systematic Review of Available Literature. Biol Trace Elem Res 2023.[66]
- Lopresti AL, Smith SJ. The effects of magnesium L-threonate (Magtein) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial. Front Nutr 2025.[67]
- Bulman A et al. The effects of L-theanine consumption on sleep outcomes: a systematic review and meta-analysis. Sleep Med Rev 2025.[68]
- Ferracioli-Oda E et al. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One 2013.[69]
- Cruz-Sanabria F et al. Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose-Response Meta-Analysis. J Pineal Res 2024.[70]
- Sateia MJ et al. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults. J Clin Sleep Med 2017.[71]
- Long-term melatonin use and heart failure — conference abstract MP2306, AHA Scientific Sessions 2025; not peer-reviewed.[72]
- Erland LA, Saxena PK. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content. J Clin Sleep Med 2017.[73]
- NIH ODS Ashwagandha Fact Sheet for Health Professionals.[74]
- McIntyre D et al. Ashwagandha (Withania somnifera)-Associated Liver Injury: A Scoping Review of Clinical Characteristics and Safety Considerations. Cureus 2026.[75]
- Bannai M, Kawai N. New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. J Pharmacol Sci 2012.[76]
- Valente V et al. Does valerian work for insomnia? An umbrella review of the evidence. Eur Neuropsychopharmacol 2024.[77]
- Florian J et al. Cannabidiol and Liver Enzyme Level Elevations in Healthy Adults: A Randomized Clinical Trial. JAMA Intern Med 2025.[78]
- Edinger JD et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2021.[79]